DPIIT recognised startup Government of India
Startup India
Ambitree India Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹6.75 Cr
▼ 4% YoY
Net profit · FY 2024
₹5.42 Lakh
Net margin 0.8%
EBITDA · FY 2024
₹10.19 Lakh
EBITDA margin 1.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Ambitree India Private Limited
Data last updated:
Ambitree India Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2019PTC349195. Its GSTIN is 07AASCA2187P1ZV (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lakshay Khanna and Meenu Khaneja.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 23 Shop No. 103 F/F Community Center – 5 E – 11 Parmesh Bussness Center – 2 Karkardo, Oma, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.75 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹5.42 Lakh (net margin 0.8%) and EBITDA of ₹10.19 Lakh (EBITDA margin 1.5%). Revenue has declined at a compounded annual rate (CAGR) of 40% over three years.
For more details, the company can be reached via its website ambitreeindia.in.
Company details
CIN U24290DL2019PTC349195
Registration Number 349195
Incorporation Date 26 April 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Key People
Lakshay Khanna Director Meenu Khaneja Director Recognitions & Rankings of Ambitree India
Contact details
Ambitree India Private Limited's registered office is in Delhi, Delhi. Its website is ambitreeindia.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No – 23 Shop No. 103 F/F Community Center – 5 E – 11 Parmesh Bussness Center – 2 Karkardo, Oma, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ambitree India Private Limited, buy the company report.
Comprehensive company report
Ambitree India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ambitree India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ambitree India Private Limited, buy the company report.
Financials of Ambitree India Private Limited
FY 2025 filings availableAmbitree India Private Limited reported revenue of ₹6.75 Cr (down 4% YoY) for FY 2024.
Revenue · FY 2024
₹6.75 Cr ▼ 4%
Net profit · FY 2024
₹5.42 Lakh margin 0.8%
EBITDA · FY 2024
₹10.19 Lakh margin 1.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▼ 40%
EBITDA CAGR growth
1 year
▲ 57%
3 years · compounded
▼ 12%
Revenue has declined at a compounded annual rate (CAGR) of 40% over three years, including a 4% fall in the latest year. EBITDA rose 57% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.19 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.42 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ambitree India Private Limited, buy the company report.
Board of directors of Ambitree India Private Limited
Ambitree India has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lakshay Khanna Also directs: Ambitree Healthcare LLP | Director | 26 Apr 2019 | 7 Years 5 Months | Current |
| Meenu Khaneja Also directs: Kritajna Beauty World Private Limited, Shree Gobind Pharmaceuticals Private Limited, Radicon Laboratories Limited. and 1 more | Director | 26 Apr 2019 | 7 Years 5 Months | Current |
Peer comparison
Ambitree India Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gliesse Pharmaceuticals Private Limited | ₹6.78 Cr (FY 2025) | 22.0% | Ahmedabad, Gujarat, India | |||
| Eshmun Biotech Private Limited | ₹6.77 Cr (FY 2025) | 68.0% | Bathinda, Punjab, India | |||
| Sanora Pharmaceuticals Private Limited | ₹6.77 Cr (FY 2025) | 39.0% | Mumbai, Maharashtra, India | |||
| Ambitree India Private Limitedthis company | ₹6.75 Cr (FY 2024) | ₹5.42 Lakh | 0.8% | -4.0% | Delhi, India | |
| Biomade Life Care Private Limited | ₹6.74 Cr (FY 2024) | 4.0% | Mohali, Punjab, India | |||
| Samnova Pharmaceuticals Private Limited | ₹6.74 Cr (FY 2025) | 55.0% | Ahmedabad, Gujarat, India | |||
| Creative Diagnostic Medicare Private Limited | ₹6.73 Cr (FY 2025) | 5.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Ambitree India Private Limited, buy the company report.
Auditor
Ambitree India Private Limited is audited by S P MARWAHA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S P MARWAHA & CO | FY 2023 | 000229N |
Shareholding
The shareholding of Ambitree India Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Ambitree India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ambitree India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ambitree India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ambitree India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AASCA2187P1ZV | Delhi | Active | 25 Jun 2019 |
To see the full GST registrations and return filing status of Ambitree India Private Limited, buy the company report.
Recent activity
Ambitree India Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Lakshay Khanna was appointed as Director on 26 Apr 2019.
AGM
Ambitree India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ambitree India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Lakshay Khanna was appointed as Director.
Appointed
Meenu Khaneja was appointed as Director.
Incorporation
26 Apr 2019
Ambitree India Private Limited was registered on 26 Apr 2019 with Roc Delhi & aged 7 years 6 months as per MCA records.
Frequently asked questions
Ambitree India is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 April 2019 (7+ years old) and is registered under CIN U24290DL2019PTC349195.
Ambitree India has 2 current directors:
- Lakshay Khanna - Director
- Meenu Khaneja - Director
The latest financial statements of Ambitree India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Ambitree India is 07AASCA2187P1ZV, registered in Delhi.
The CIN (Corporate Identification Number) of Ambitree India is U24290DL2019PTC349195. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ambitree India was incorporated on 26 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ambitree India by revenue are Gliesse Pharmaceuticals Private Limited, Eshmun Biotech Private Limited, Sanora Pharmaceuticals Private Limited, Biomade Life Care Private Limited, Samnova Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Lakshay Khanna was appointed as Director on 26 Apr 2019. Meenu Khaneja was appointed as Director on 26 Apr 2019.
Yes, Ambitree India is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Ambitree India can be reached through the website ambitreeindia.in. Its registered office is in Delhi, India.
The registered office of Ambitree India is at Plot No – 23 Shop No. 103 FF Community Center – 5 E – 11 Parmesh Bussness Center – 2 Karkardo, Oma, Delhi, India – 110092.